ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Elicera Therapeutics' new issue heavily oversubscribed firstwordpharma
June 10, 2021?Elicera Therapeutics announced today that the Company's issue of units of approximately SEK 52 million prior to the planned listing on the Nasdaq First North Growth Market was subscribed for approximately 171 percent spread over about 3 600 subscribers.
Pharma Sources Insight January 2025
